Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies
PALO ALTO, Calif., April 19, 2018 -- (Healthcare Sales &Marketing Network) -- Varian (NYSE: VAR) today announced it is incorporating new imaging technologies in the Halcyon 2.0 treatment system to expand its capabilities and ability to deliver high qual... Devices, Oncology Varian Medical Systems, Halcyon System, IMRT, radiotherapy
CONCLUSION: Induction chemotherapy seems to have a negative impact on patient's compliance to CCRT. Bulky tumors and prolonged radiation interruptions were associated with significantly lower LRC, DFS and OS. PMID: 32458648 [PubMed - in process]
This year's ASCO is virtual. Any interesting abstracts seen? Meeting Library | Meeting Library meetinglibrary.asco.org Proven benefit of IMRT to spare swallowing function in H&N cancer Meeting Library | Meeting Library meetinglibrary.asco.org Randomized dose deescalation after TORS for P16 H&N cancer Meeting Library | Meeting Library ...
Radiation therapy plays a critical role in the treatment of esophageal cancer (EC), especially for locally advanced EC . Historically, three-dimensional conformal radiotherapy (3DCRT) has been the most widely used radiation technique for EC. Based on inverse planning algorithm and complex modulated beams, IMRT can provide improved target coverage and better sparing of organs at risk (OARs) . Therefore, as an advanced conformal radiation modality, intensity-modulated radiotherapy (IMRT) has been increasingly adopted worldwide over the past decade [3,4].
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Radiation: Intensity-modulated Radiation Therapy (IMRT) Sponsor: University of Texas Southwestern Medical Center Not yet recruiting
Conclusion: Neoadjuvant therapy for borderline resectable and resectable pancreatic ductal adenocarcinoma with CRT facilitated R0 resection in 84% patients who underwent surgery.
To investigate the loco-regional progression-free survival (LPFS) of intensity-modulated radiotherapy (IMRT) with different fraction sizes for locally advanced non-small-cell lung cancer (LANSCLC), and to appl...
ConclusionThe combined OS and DFS rates of rNPC patients treated with endoscopic nasopharyngectomy were summarized and reported in our study. This meta ‐analysis indicated that endoscopic nasopharyngectomy has comparable and possibly better treatment outcomes than intensity‐modulated radiotherapy (IMRT). Therefore, the result of our study indicated that randomized controlled trials (RCTs) are needed in rNPC patients to compare treatment outcome s of endoscopic nasopharyngectomy vs IMRT.
ConclusionAfter great improvements in rectal cancer treatment, late gastrointestinal toxicity after radiotherapy is experienced less frequent and less severe; however, it remains a great concern associated with worse quality of life.
The use of a specific treatment technique in radiation therapy is mainly motivated by the achievable dose conformity to the target and the overall integral dose. Proton therapy offers a highly conformal and comprehensive treatment option with a lower integral dose (reduced low-dose bath) to organs at risk (OARs). Consequently, given the proximity of cardiopulmonary structures, proton therapy has been discussed as a treatment alternative for breast cancer patients [1 –3]. Treatment planning studies, comparing 3DCRT, IMRT, and proton therapy when irradiating the breast and regional nodes showed advantages of using prot...
CONCLUSIONS: Air cavities inside rectum affects rectum plan dosimetry due ERE. Location and magnitude of hot spots are dependent on the size of the air cavity. PMID: 32445292 [PubMed - as supplied by publisher]